BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30171991)

  • 21. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
    Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
    Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial metastasis of a primitive neuroendocrine ovarian carcinoma: management and treatment of a case.
    Tartaglia E; Di Serio C; Rotondi M; Di Serio M; Scaffa C; Tolino A
    Eur J Gynaecol Oncol; 2008; 29(1):101-4. PubMed ID: 18386478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development.
    Miura K; Nasu H; Ogura H
    Pathol Int; 2012 May; 62(5):331-4. PubMed ID: 22524661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulinoma-associated protein 1 is a sensitive and specific marker for lung neuroendocrine tumors in cytologic and surgical specimens.
    Viswanathan K; Siddiqui MT; Borczuk AC
    J Am Soc Cytopathol; 2019; 8(6):299-308. PubMed ID: 31345782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroendocrine Marker Expression in Primary Non-neuroendocrine Epithelial Tumors of the Ovary: A Study of 551 Cases.
    Kendall Bártů M; Němejcová K; Michálková R; Bui QH; Drozenová J; Fabian P; Fadare O; Hausnerová J; Laco J; Matěj R; Méhes G; Šafanda A; Singh N; Škapa P; Špůrková Z; Stolnicu S; Švajdler M; Lax SF; McCluggage WG; Dundr P
    Int J Gynecol Pathol; 2024 Mar; 43(2):123-133. PubMed ID: 37406366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate carcinoma with amphicrine features: further refining the spectrum of neuroendocrine differentiation in tumours of primary prostatic origin?
    Prendeville S; Al-Bozom I; Compérat E; Sweet J; Evans AJ; Ben-Gashir M; Mete O; van der Kwast TH; Downes MR
    Histopathology; 2017 Dec; 71(6):926-933. PubMed ID: 28756619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Twelve cases of neuroendocrine carcinomas of the uterine cervix: cytology, histopathology and discussion of their histogenesis.
    Li S; Zhu H
    Acta Cytol; 2013; 57(1):54-60. PubMed ID: 23221311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. INSM1 Is Less Sensitive But More Specific Than Synaptophysin in Gynecologic High-grade Neuroendocrine Carcinomas: An Immunohistochemical Study of 75 Cases With Specificity Test and Literature Review.
    Zou Q; Zhang L; Cheng Z; Guo X; Cao D
    Am J Surg Pathol; 2021 Feb; 45(2):147-159. PubMed ID: 33264139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.
    Righi L; Sapino A; Marchiò C; Papotti M; Bussolati G
    Semin Diagn Pathol; 2010 Feb; 27(1):69-76. PubMed ID: 20306832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical study.
    Giordano G; Berretta R; Silini E
    Diagn Pathol; 2016 Aug; 11(1):70. PubMed ID: 27491291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine carcinoma of uterine cervix.
    Kajiwara H; Hirabayashi K; Miyazawa M; Nakamura N; Hirasawa T; Muramatsu T; Mikami M; Yasuda M; Osamura RY
    Arch Gynecol Obstet; 2009 Apr; 279(4):521-5. PubMed ID: 18726606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
    Bahrami A; Gown AM; Baird GS; Hicks MJ; Folpe AL
    Mod Pathol; 2008 Jul; 21(7):795-806. PubMed ID: 18487991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study.
    Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J
    Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?
    Machado I; Navarro S; López-Guerrero JA; Verdini L; Picci P; Giner F; Llombart-Bosch A
    Pathol Res Pract; 2021 Mar; 219():153362. PubMed ID: 33610950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and prognosis.
    Ishida M; Sekine S; Fukagawa T; Ohashi M; Morita S; Taniguchi H; Katai H; Tsuda H; Kushima R
    Am J Surg Pathol; 2013 Jul; 37(7):949-59. PubMed ID: 23759931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathologic diagnosis and differential diagnosis of small cell neuroendocrine carcinoma of kidney].
    Guo AT; Huang H; Wei LX
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):538-42. PubMed ID: 23157746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastatic large cell neuroendocrine carcinoma of the lung arising from the uterus: A pitfall in lung cancer diagnosis.
    Ono K; Yokota NR; Yoshioka E; Noguchi A; Washimi K; Kawachi K; Miyagi Y; Kato H; Yokose T
    Pathol Res Pract; 2016 Jul; 212(7):654-7. PubMed ID: 27113439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
    Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
    Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic significance of neuroendocrine markers and somatostatin receptor 2 in hepatocellular carcinoma.
    Murakami K; Kumata H; Miyagi S; Kamei T; Sasano H
    Pathol Int; 2021 Oct; 71(10):682-691. PubMed ID: 34320691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.